Clinical Trial Update: Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing single versus repeated intracoronary autologous bone marrow–derived mononuclear cell therapy in chronic post-infarction heart failure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Autologous bone marrow-derived mononuclear cells (bone marrow-derived mononuclear cells)

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Heart Failure | Phase 2, Phase 3 | Status: UNKNOWN